0001683168-18-002921.txt : 20181003 0001683168-18-002921.hdr.sgml : 20181003 20181002192749 ACCESSION NUMBER: 0001683168-18-002921 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180926 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20181003 DATE AS OF CHANGE: 20181002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gala Pharmaceutical Inc. CENTRAL INDEX KEY: 0001513403 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 421771014 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-172744 FILM NUMBER: 181103226 BUSINESS ADDRESS: STREET 1: 18881 VON KARMAN AVE. STREET 2: SUITE 1440 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-851-9261 MAIL ADDRESS: STREET 1: 18881 VON KARMAN AVE. STREET 2: SUITE 1440 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Gala Pharmaceuticals Inc. DATE OF NAME CHANGE: 20180202 FORMER COMPANY: FORMER CONFORMED NAME: Gala Pharmaceutical Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Gala Global Inc. DATE OF NAME CHANGE: 20110217 8-K 1 gala_8k-092618.htm FORM 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

September 26, 2018
Date of Report (Date of earliest event reported)

 

GALA PHARMACEUTICAL INC.

(Exact name of registrant as specified in its charter)

 

NEVADA 000-52044 42-1771014
(State or other jurisdiction of (Commission File (IRS Employer Identification No.)
incorporation) Number)  

 

     
18881 Von Karman, Suite 1440 , Irvine California 92660
(Address of principal executive offices) (Zip Code)

 

(949) 851-9261

Registrant's telephone number, including area code

 

_________2780 South Jones Blvd. #3725 Las Vegas, Nevada 89146_________
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

____ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

____ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

ITEM 5.02.DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS

 

Ms. Romina Martinez resigned as a director with the Company effective as of September 26, 2016. The resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

ITEM 9.01EXHIBITS

 

(b)

 

Exhibit No.   Exhibit
17.3   Resignation of Romina Martinez

 

 

 

 

 

 

 

 

 

 

 2 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

/s/ Maqsood Rehman   Date
     
Maqsood Rehman    
Chief Executive Officer   October 2, 2018

 

 

 

 

 3 

 

 EX-17.3 2 gala_8k-ex1703.htm RESIGNATION

Exhibit 17.3

 

 

RESIGNATION

 

 

 

 

TO: GALA PHARMACEUTICAL, INC.

 

AND TO: THE BOARD OF DIRECTORS THEREOF

 

I, ROMINA MARTINEZ, hereby tender my resignation as a Director of GALA PHARMACEUTICAL INC.

 

Effective upon acceptance.

 

DATED at this 26st Day of September, 2018.

 

Romina Martinez

 

/s/ Romina Martinez